Global X - Genomics and Biotechnology ETF (GNOM) |
| 55.7649 0.155 (0.28%) 07-14 16:00 |
| Open: | 55.345 |
| High: | 56.04 |
| Low: | 55.345 |
| Volume: | 41,174 |
| Market Cap: | 86(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management - Global |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 69.47 |
| Resistance 1: | 59.48 |
| Pivot price: | 56.55 |
| Support 1: | 51.87 |
| Support 2: | 47.16 |
| 52w High: | 59.48 |
| 52w Low: | 34.04 |
The Global X Genomics & Biotechnology ETF, known by its ticker GNOM, aims to closely track the performance of the Solactive Genomics Index, reflecting both its price appreciation and any generated income. This mirroring occurs before the deduction of the ETF's internal fees and expenses.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 07 Jul 2026
Trading the Move, Not the Narrative: (GNOM) Edition - Stock Traders Daily
Mon, 29 Jun 2026
Genomics & biotechnology ETF declares semi-annual distribution of $0.057900 - MSN
Mon, 11 May 2026
Best CRISPR Gene Editing ETFs for 2026 and How to Invest - The Motley Fool
Tue, 17 Mar 2026
The Zacks Analyst Blog Highlights IBB, XBI, BBH and GNOM - Yahoo Finance
Mon, 16 Mar 2026
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI Wave - TradingView
Wed, 11 Feb 2026
7 Best Biotech ETFs to Buy Now - U.S. News - Money
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
